Overview


 

According to FutureWise analysis, the market for Biosurgery is expected to reach US$ 19,821.19 million in 2030 growing at a CAGR of 5.5%.

Biosurgery refers to the use of surgical sealants, hemostatic agents, bone graft substitutes, soft tissue management, and adhesion prevention products to promote the healing of tissues and prevent post-surgical complications. Biosurgery products are used in various surgical procedures to promote tissue regeneration, reduce post-operative complications, and improve patient outcomes. One of the primary uses of biosurgery products is to achieve hemostasis, which is preventing or controlling bleeding during surgical procedures. Hemostatic agents, such as fibrin sealants and collagen-based products, are used to promote clotting and reduce bleeding. These products are particularly useful in surgeries that involve delicate or vascular tissues, such as neurosurgery, cardiac surgery, and orthopedic surgery.

Bone graft substitutes, for example, are used to stimulate bone growth and promote fusion in spinal surgeries or cases of bone fractures. Soft tissue management products, such as surgical meshes and patches, are used to reinforce or repair soft tissues, such as ligaments and tendons, in procedures such as hernia repair and breast reconstruction. Adhesion prevention products are another important use of biosurgery products. Adhesions are abnormal connections that form between organs and tissues following surgery or injury and can lead to pain, bowel obstruction, and infertility. Adhesion prevention products, such as films and gels, are used to prevent the formation of adhesions following surgery.

FutureWise Market Research has published a report that provides an insightful analysis of Biosurgery Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Biosurgery Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.
  • Johnson And Johnson
  • Baxter International Inc.
  • Medtronic Plc
  • Becton, Dickinson Co.
  • Tissue Regenix Group Plc
  • Stryker Corp.
  • Integra Lifesciences Holdings Corp.
  • CSL Ltd.
  • Hemostasis LLC.
  • Pfizer Inc.
  • Cyrolife Inc.
  • Zimmer Biomet
  • Kuros Biosciences AG
  • Orthofix Medical Inc.
  • Smiths And Nephew Plc.
  • Tissue Regenix Group Plc
  • Betatech Medical
  • Meril Lifesciences Pvt. Ltd.
  • RTI Surgicals
  • Samyang Holdings Corp.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Biosurgery Market:

  • In April 2021, Myriad Morcells, a morselized (powder) variant of Myriad Matrix that readily optimises interaction with uneven wound beds, was developed by Aroa Biosurgery Ltd, a soft tissue regeneration company.

The biosurgery market is expected to grow significantly in the coming years due to numerous factors, including the growing demand for minimally invasive surgeries, the growing elderly population, and the increasing frequency of chronic illnesses. Biosurgery involves the use of surgical sealants, hemostatic agents, bone graft substitutes, soft tissue management, and adhesion prevention products to promote the healing of tissues and prevent post-surgical complications. The growing frequency of chronic diseases such as cancer, cardiovascular diseases, and diabetes drives the demand for biosurgery products. These products help in the prevention of excessive bleeding during surgeries and promote the healing of tissues, reducing the need for repeat surgeries. Moreover, the growing geriatric population is also driving to the growth of the biosurgery market. As the elderly population is more prone to chronic diseases and requires surgeries, there is a high demand for biosurgery products to ensure faster healing and reduce post-surgical complications. Additionally, the demand for minimally invasive surgeries is increasing due to their numerous benefits, such as reduced pain, less scarring, and shorter hospital stays. The use of biosurgery products in minimally invasive surgeries promotes faster healing and reduces the risk of post-surgical complications.

However, biosurgery products, such as surgical sealants, hemostatic agents, and bone graft substitutes, can be expensive, which may limit their use, particularly in developing countries with well-established healthcare infrastructure. The high costs associated with biosurgery products are often due to their complex manufacturing processes, research and development costs, and regulatory requirements. Another factor that may hinder market growth is the lack of awareness and expertise among healthcare professionals regarding the use of biosurgery products. Biosurgery products require specialized training and skills to use them effectively, and many healthcare professionals may not be familiar with these products or how to use them. As a result, healthcare providers may not prescribe or use biosurgery products, limiting market growth.

By Product Type

  • Bone Graft Substitutes
    • Demineralized bone matrix
    • Synthetic Bone Grafts
    • Bone Morphogenetic Proteins
    • Other Bone-Graft Substitutes
  • Soft-tissue attachments
    • Synthetic meshes
    • Biological meshes
      • Allografts
      • Xenografts
  • Hemostatic agents
    • Thrombin-based hemostatic agents
    • Oxidized regenerated cellulose-based hemostatic agents
    • Combination hemostatic agents
  • Surgical sealants and adhesives
    • Natural/Biological Sealants and Adhesives
      • Natural/Biological Sealants and Adhesives, By Type
        • Fibrin Sealants
        • Collagen-Based Sealants
        • Gelatin-Based Sealants
        • Albumin-Based Sealants
        • Other Natural/Biological Sealants
      • Natural/Biological Sealants and Adhesives, By Origin
        • Human Blood-Based Sealants and Adhesives
        • Animal-Based Sealants and Adhesives
    • Synthetic and Semi-Synthetic Sealants and Adhesives
      • Peg Hydrogels
      • Cyanoacrylate-Based Sealants and Adhesives
      • Urethane-Based Sealants and Adhesives
      • Other Synthetic and Semi-Synthetic Sealants and Adhesives
  • Adhesion Barriers
    • Synthetic Adhesion Barriers
      • Hyaluronic Acid-Based Adhesion Barriers
      • Regenerated Cellulose-Based Adhesion Barriers
      • Peg-Based Adhesion Barriers
      • Other Synthetic Adhesion Barriers
    • Natural Adhesion Barriers
      • Collagen And Protein Adhesion Barriers
      • Fibrin-Based Adhesion Barriers
  • Staple-Line Reinforcement Agents

By Application

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Reconstructive Surgery
  • Gynecological Surgery
  • Urological Surgery
  • Thoracic Surgery
  • Others

By End User

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the global market. Throughout the projected period, North America is anticipated to command the global market. This is attributed to an increase in the number of procedures, a rise in the number of elderly patients, and market participants' activities. One of the key factors driving the market expansion in this region is the high cost of surgery. For instance, the National Safety Council reports that in July 2021, there were 341,000 injuries from football, 500,000 from basketball, 457,000 from bicycles, and 526,000 from personal exercise. 199,000 swimming-related injuries were addressed in emergency rooms, according to NSC. Over 50% of these injuries were knee, shoulder, head, and spinal-related. Thus, when more accidents occur requiring surgery, there is a greater demand for biosurgery goods, propelling the market's expansion. Additionally, based on product; Bone graft substitutes segment, and based on end-user, hospitals dominated the global market in 2022.
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the global bio surgery market by product type, by application, by end user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and the Middle East Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Biosurgery Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Biosurgery Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Biosurgery Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Biosurgery Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Bone Graft Substitutes
         1.1. Demineralized bone matrix
         1.2. Synthetic Bone Grafts
         1.3. Bone Morphogenetic Proteins
         1.4. Other Bone-Graft Substitutes
        2. Soft-tissue attachments
         2.1. Synthetic meshes
         2.2. Biological meshes
          2.2.1. Allografts
          2.2.2. Xenografts
        3. Hemostatic agents
         3.1. Thrombin-based hemostatic agents
         3.2. Oxidized regenerated cellulose-based hemostatic agents
         3.3. Combination hemostatic agents
        4. Surgical sealants and adhesives
         4.1. Natural/Biological Sealants and Adhesives
          4.1.1. Natural/Biological Sealants and Adhesives, By Type
           4.1.1.1. Fibrin Sealants
           4.1.1.2. Collagen-Based Sealants
           4.1.1.3. Gelatin-Based Sealants
           4.1.2.4. Albumin-Based Sealants
           4.1.2.5. Other Natural/Biological Sealants
          4.2.2. Natural/Biological Sealants and Adhesives, By Origin
           4.2.2.1. Human Blood-Based Sealants and Adhesives
           4.2.2.2. Animal-Based Sealants and Adhesives
         4.2. Synthetic and Semi-Synthetic Sealants and Adhesives
          4.2.1. Peg Hydrogels
          4.2.2. Cyanoacrylate-Based Sealants and Adhesives
          4.2.3. Urethane-Based Sealants and Adhesives
          4.2.4. Other Synthetic and Semi-Synthetic Sealants and Adhesives
        5. Adhesion Barriers
         5.1. Synthetic Adhesion Barriers
          5.1.1. Hyaluronic Acid-Based Adhesion Barriers
          5.1.2. Regenerated Cellulose-Based Adhesion Barriers
          5.1.3. Peg-Based Adhesion Barriers
          5.1.4. Other Synthetic Adhesion Barriers
         5.2. Natural Adhesion Barriers
          5.2.1. Collagen And Protein Adhesion Barriers
          5.2.2. Fibrin-Based Adhesion Barriers
        6. Staple-Line Reinforcement Agents

  • 8.   Global Biosurgery Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Orthopedic Surgery
        2. General Surgery
        3. Neurological Surgery
        4. Cardiovascular Surgery
        5. Reconstructive Surgery
        6. Gynecological Surgery
        7. Urological Surgery
        8. Thoracic Surgery
        9. Others

  • 9.   Global Biosurgery Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospitals
        2. Clinics
        3. Others

  • 10.   North America Biosurgery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Biosurgery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Biosurgery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Biosurgery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Johnson And Johnson
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Baxter International Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Medtronic Plc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Becton, Dickinson Co.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Tissue Regenix Group Plc
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Stryker Corp.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Integra Lifesciences Holdings Corp.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. CSL Ltd.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Hemostasis LLC.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Pfizer Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Cyrolife Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Zimmer Biomet
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13.Kuros Biosciences AG
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14.Orthofix Medical Inc.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15.Smiths And Nephew Plc.
                 15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16.Tissue Regenix Group Plc
         1. Company Overview
         2. Product Portfolio
         3. SWOT Analysis
         4. Financial Overview
         5. Strategic Overview
        17.Betatech Medical
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18.Meril Lifesciences Pvt. Ltd.
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
            19. RTI Surgicals
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
             20. Samyang Holdings Corp. 
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11